Search
Transmedics Group Inc
TMDXAdd to Watchlist
72.260USD
+1.130+1.59%
Close 07-24 16:00（ET）Quotes delayed by 15 min
2.50BMarket Cap
14.31P/E TTM
Earnings Forecast
Currency: USD Updated: 2026-07-24The current earnings forecast score of Transmedics Group Inc is 7.85, ranking 119 out of 200 in the Healthcare Equipment & Supplies industry. The average price target is 148.50, with a high of 170.00 and a low of 114.00.
Analyst Rating
Based on
12
analysts
Buy
Current Rating
118.444
Target Price
+66.52%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
88
Total
4
Median
7
Average
Company name
Ratings
Analysts
Transmedics Group Inc
TMDX
12
Intuitive Surgical Inc
ISRG
35
Boston Scientific Corp
BSX
34
Edwards Lifesciences Corp
EW
33
Thermo Fisher Scientific Inc
TMO
30
Veeva Systems Inc
VEEV
30
1
2
3
...
18
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is Transmedics Group Inc's expected revenue for the next quarter?
Transmedics Group Inc's expected revenue is 183.36M.
What is Transmedics Group Inc's price target?
Analysts forecast that Transmedics Group Inc's price target is USD 148.50, with the highest forecast at USD 170.00 and the lowest forecast at USD 114.00.
How have Transmedics Group IncTMDX's recent earnings per share performed?
The market expectation was USD 0.21, while Transmedics Group IncTMDX's earnings per share (EPS) for the previous quarter was USD 3.08. EPS for the next quarter is expected at USD 0.46.
What is the analyst rating for Transmedics Group Inc?
Based on the ratings of Transmedics Group Inc's stock from 12 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.